Literature DB >> 10205006

Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.

H Racchi1, M J Irarrázabal, M Howard, S Morán, R Zalaquett, J P Huidobro-Toro.   

Abstract

1. Human saphenous veins were used to assess the cooperative participation of adenosine 5-triphosphate (ATP), neuropeptide Y (NPY), and noradrenaline (NA) in the vasomotor responses elicited following electrical depolarization of the perivascular nerve terminals. Rings from recently dissected human biopsies were mounted to record isometric muscular contractions; the motor activity elicited in the circular muscle layer following electrical depolarization (2.5-20 Hz, 50 V, 0.5 msec) were recorded. 2. Incubation of the biopsies with either 100 nM tetrodotoxin (TTX) or 1 microM guanethidine abolished the vasomotor response elicited by electrical nerve depolarization. The independent application of either ATP or NA to vein rings induced concentration-dependent contractions. 3. Tissue incubation with 30 microM suramin or 10 nM prazosin produced 10 fold rightward displacements of the alpha,beta-methylene ATP and NA concentration-response curves respectively. NPY contracted a limited number of biopsies, the vasoconstriction elicited was completely blocked by 1 microM BIBP 3226. A 5 min incubation of the biopsies with 10-100 nM NPY synergized, in a concentration-dependent fashion, both the ATP and the ATP analogue-induced contractions. Likewise, tissue preincubation with 10 nM NPY potentiated the vasomotor responses evoked with 20-60 nM NA. 4. Neither suramin, BIBP 3226, nor prazosin was individually able to significantly modify the derived frequency-tension curves. In contrast, the co-application of 30 microM suramin and 10 nM prazosin or 30 microM suramin and 1 microM BIBP 3226, elicited a significant (P<0.01) downward displacement of the respective frequency-tension curves. 5. The simultaneous application of the three antagonists-30 microM suramin, 1 microM BIBP 3226 and 10 nM prazosin-caused a significantly greater displacement of the frequency-tension curve than that achieved in experiments using two of these antagonists. 6. Electrically-evoked vasomotor activity is blocked to a larger extent by tissue incubation with 2.5 microM chloroethylclonidine and 30 microM suramin rather than with 10 nM 5 methyl urapidil and 30 microM suramin. As a result, the alpha1-adrenoceptor involved in the vasomotor activity has tentatively been associated with the alpha1B adrenoceptor family subtype. 7. Results support the physiological role of ATP in sympathetic neurotransmission. The present results are consistent with the working hypothesis that human sympathetic vasomotor reflexes involve the coordinated motor action of ATP, NPY, and NA acting on vascular smooth muscle cells. The present results support the concept of sympathetic co-transmission in the human saphenous vein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205006      PMCID: PMC1565874          DOI: 10.1038/sj.bjp.0702396

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y.

Authors:  L H Pheng; A Fournier; Y Dumont; R Quirion; D Regoli
Journal:  Eur J Pharmacol       Date:  1997-05-30       Impact factor: 4.432

Review 2.  Signaling by extracellular nucleotides.

Authors:  A J Brake; D Julius
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

Review 3.  Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.

Authors:  R E Malmström
Journal:  Acta Physiol Scand Suppl       Date:  1997

4.  Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation.

Authors:  H Racchi; A J Schliem; M V Donoso; A Rahmer; A Zúñiga; S Guzmán; K Rudolf; J P Huidobro-Toro
Journal:  Eur J Pharmacol       Date:  1997-06-18       Impact factor: 4.432

5.  Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.

Authors:  A Bergdahl; T Nilsson; L Cantera; L Nilsson; X Y Sun; T Hedner; D Erlinge; S Valdemarson; L Edvinsson
Journal:  Eur J Pharmacol       Date:  1996-11-28       Impact factor: 4.432

6.  Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.

Authors:  R E Malmstrom; J M Lundberg
Journal:  Eur J Pharmacol       Date:  1995-12-29       Impact factor: 4.432

7.  BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.

Authors:  M V Donoso; M Steiner; J P Huidobro-Toro
Journal:  J Pharmacol Exp Ther       Date:  1997-08       Impact factor: 4.030

8.  Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries.

Authors:  T Nilsson; L Cantera; L Edvinsson
Journal:  Neurosci Lett       Date:  1996-02-09       Impact factor: 3.046

9.  Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres.

Authors:  J A Brock; T C Cunnane
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

10.  Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101.

Authors:  K P Minneman; C Han; P W Abel
Journal:  Mol Pharmacol       Date:  1988-05       Impact factor: 4.436

View more
  16 in total

1.  Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Sympathetic control of reflex cutaneous vasoconstriction in human aging.

Authors:  Jody L Greaney; Lacy M Alexander; W Larry Kenney
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

3.  Neurogenic double-peaked vasoconstriction of human gastroepiploic artery is mediated by both alpha1- and alpha2-adrenoceptors.

Authors:  Daisuke Fukui; Xiao-Ping Yang; Shigetoshi Chiba
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  Modulation of sympathetic neurotransmission by neuropeptide Y Y2 receptors in rats and guinea pigs.

Authors:  Erica K Potter; Diana Tripovic
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

5.  Existence of different alpha(1)-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries.

Authors:  X P Yang; S Chiba
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

6.  Neurovascular mechanisms underlying augmented cold-induced reflex cutaneous vasoconstriction in human hypertension.

Authors:  Jody L Greaney; W Larry Kenney; Lacy M Alexander
Journal:  J Physiol       Date:  2017-01-16       Impact factor: 5.182

7.  Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase.

Authors:  Mitsuo Mita; Hayato Yanagihara; Shigeru Hishinuma; Masaki Saito; Michael P Walsh
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

8.  Local tetrahydrobiopterin administration augments cutaneous vasoconstriction in aged humans.

Authors:  James A Lang; Lacy A Holowatz; W Larry Kenney
Journal:  J Physiol       Date:  2009-06-02       Impact factor: 5.182

9.  P2Y1 and P2Y2 receptor distribution varies along the human placental vascular tree: role of nucleotides in vascular tone regulation.

Authors:  Sonja Buvinic; M Inés Poblete; M Verónica Donoso; Ana María Delpiano; René Briones; Ramiro Miranda; J Pablo Huidobro-Toro
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

10.  Altered neurotransmitter control of reflex vasoconstriction in aged human skin.

Authors:  Caitlin S Thompson; W Larry Kenney
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.